measurement
In vivo experiments in senescent cell-transplanted young mice and naturally aged mice showed that intermittent oral administration of Dasatinib plus quercetin alleviated physical dysfunction, reduced mortality hazard to 65%, and increased post-treatment survival by 36%.

Authors

Sources

Referenced by nodes (1)